Cost cards / follow-up
What comes after the first visit?
A plan that looks affordable at the start needs another look at what comes next.
What follow-up am I paying for?
Ask how you can contact the doctor or other health professional who treated you after the visit. Find out who answers if you feel ill and which check-ins cost extra.
- Who reviews how I am doing?
- How can I ask about a new symptom?
- Are extra visits charged separately?
- Who reads any repeat test results?
- What happens if treatment is not a good fit?
Is the first price a lasting price?
As of September 26, 2026, several cash offers and drug makers’ coupons to reduce medicine bills had terms ending on December 31, 2026.
That end date did not say what the replacement terms would be.
Ask for the later price and any notice given before it changes. Keep your own copy of the answer.
Open the source note
Ask what you would pay after the offer ends. The end date alone does not tell you that price.
What do we know about stopping?
Semaglutide is the medicine in Ozempic and Wegovy. In the STEP 1 follow-up study, people gained back roughly two-thirds of their lost weight during the year after stopping treatment.
The study does not tell you how long each person will need treatment.
For CagriSema, which pairs cagrilintide with semaglutide, no published result about weight after stopping had been found by September 28, 2026.
Ask how a care plan would handle stopping or changing treatment. Do not borrow a semaglutide answer for cagrilintide.
Open the source note
The result after stopping belongs to semaglutide; the combination’s longer-term question remained open.